InvestorsHub Logo
Followers 108
Posts 4135
Boards Moderated 0
Alias Born 04/21/2011

Re: tbarber post# 98504

Tuesday, 03/11/2014 10:45:51 PM

Tuesday, March 11, 2014 10:45:51 PM

Post# of 194796
The businesses of LBGE and FITX really have nothing in common. The business of LBGE was a completely different and unrelated type of business, and went defunct so Creative Edge reverse merged into the LBGE shell in 2011 in order to be able to expedite the process of becoming public. The initial CEO of Creative Edge named after the reverse merge was Paul Thomas. He was/is still the CEO of EST Nutrition (so he was wearing two hats). At that point, Creative Edge had 1 product in R+D (Metabolic Xtreme), which he basically dropped the ball on, as well as getting Creative Edge going (I'm guessing may have also been some concern with competing products with his personal nutrition company). Bill Chaaban was then brought in to replace him in April 2012. Shortly after becoming CEO, Bill started really getting the business going. Not only did he bring Metabolic Xtreme to market, but he quickly brought several other products through R+D and to market, including AminoPlex and HyperInfusion. Bill also quickly wanted to get a ticker change to reflect the current business which had nothing to do with the old business, so he had it changed from LBGE to FITX. Not only did he get the nutritional side of the company up and running strongly (which is still ongoing), he announced and began development of a MMJ subsidiary, CEN-Biotech...and we all know how much progress has been made in such a short amount of time so far. Given his track record, I have zero doubts he will make CEN-Biotech an enormous success, no matter how much nonsense blows around here up until imminent lift off...

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=98506258

FITX

All of my posts are in my opinion only, formulated from the publicly available data and information, and are not meant to be investment advice in any shape or form...